Cargando…

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutants

As global vaccination campaigns against SARS-CoV-2 proceed, there is particular interest in the longevity of immune protection, especially with regard to increasingly infectious virus variants. Neutralizing antibodies (Nabs) targeting the receptor binding domain (RBD) of SARS-CoV-2 are promising cor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Junker, Daniel, Dulovic, Alex, Becker, Matthias, Wagner, Teresa R., Kaiser, Philipp D., Traenkle, Bjoern, Kienzle, Katharina, Bunk, Stefanie, Struemper, Carlotta, Haeberle, Helene, Schmauder, Kristina, Ruetalo, Natalia, Malek, Nisar, Althaus, Karina, Koeppen, Michael, Rothbauer, Ulrich, Walz, Juliane S., Schindler, Michael, Bitzer, Michael, Göpel, Siri, Schneiderhan-Marra, Nicole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9062870/ https://www.ncbi.nlm.nih.gov/pubmed/35505068 http://dx.doi.org/10.1038/s41598-022-10987-2

Ejemplares similares

Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
por: Becker, Matthias, et al.
Publicado: (2021)

NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
por: Wagner, Teresa R, et al.
Publicado: (2021)

Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern
por: Wagner, Teresa R, et al.
Publicado: (2021)

Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants
por: Junker, Daniel, et al.
Publicado: (2022)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

Under the Microscope: Single-Domain Antibodies for Live-Cell Imaging and Super-Resolution Microscopy
por: Traenkle, Bjoern, et al.
Publicado: (2017)

External Validation of COVID-19 Risk Scores during Three Waves of Pandemic in a German Cohort—A Retrospective Study
por: Häger, Lukas, et al.
Publicado: (2022)

Reduced Intracortical Facilitation to TMS in Both Isolated REM Sleep Behavior Disorder (RBD) and Early Parkinson’s Disease with RBD
por: Lanza, Giuseppe, et al.
Publicado: (2022)

Impact of SARS-CoV-2 RBD Mutations on the Production of a Recombinant RBD Fusion Protein in Mammalian Cells
por: Gerez, Guillaume, et al.
Publicado: (2022)

Contribution of dsRBD2 to PKR Activation
por: Hesler, Stephen, et al.
Publicado: (2021)

Author Correction: Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Multi-modal Brain MRI in Subjects with PD and iRBD
por: Mangia, Silvia, et al.
Publicado: (2017)

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination
por: Dulovic, Alex, et al.
Publicado: (2022)

Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
por: Tai, Wanbo, et al.
Publicado: (2020)

Real-time analysis of epithelial-mesenchymal transition using fluorescent single-domain antibodies
por: Maier, Julia, et al.
Publicado: (2015)

Hyposmia Is Associated with RBD for PD Patients with Variants of SNCA
por: Li, Yuanyuan, et al.
Publicado: (2017)

Neurologic and psychiatric features of impending neurodegeneration in iRBD
por: Barone, Daniel A., et al.
Publicado: (2023)

Entropic contribution of ACE2 glycans to RBD binding
por: Mugnai, Mauro L., et al.
Publicado: (2023)

The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD
por: Greaney, Allison J., et al.
Publicado: (2021)

Multiepitope Proteins for the Differential Detection of IgG Antibodies against RBD of the Spike Protein and Non-RBD Regions of SARS-CoV-2
por: Gomes, Larissa R., et al.
Publicado: (2021)

RBD Double Mutations of SARS-CoV-2 Strains Increase Transmissibility through Enhanced Interaction between RBD and ACE2 Receptor
por: Sinha, Siddharth, et al.
Publicado: (2021)

Longitudinal cellular and humoral immune responses after triple BNT162b2 and fourth full-dose mRNA-1273 vaccination in haemodialysis patients
por: Becker, Matthias, et al.
Publicado: (2022)

COVID-19 in persons aged 70+ in an early affected German district: Risk factors, mortality and post-COVID care needs—A retrospective observational study of hospitalized and non-hospitalized patients
por: Herrmann, Matthias L., et al.
Publicado: (2021)

Corrigendum: Multi-modal Brain MRI in Subjects with PD and iRBD
por: Mangia, Silvia, et al.
Publicado: (2018)

Self-Assembled Particles Combining SARS-CoV-2 RBD Protein and RBD DNA Vaccine Induce Synergistic Enhancement of the Humoral Response in Mice
por: Borgoyakova, Mariya B., et al.
Publicado: (2022)

Bionics design of affinity peptide inhibitors for SARS-CoV-2 RBD to block SARS-CoV-2 RBD-ACE2 interactions
por: Liu, Xiaofeng, et al.
Publicado: (2023)

2356. Close correlation of RBD with Live Viral Neutralising Capacity Across Variants and Time Supports Use of RBD Thresholds to Predict Protective Host Immunity
por: Kenny, Grace, et al.
Publicado: (2023)

EOS deployment on Ceph RBD/CephFS with K8s
por: Fornari, Federico, et al.
Publicado: (2023)

REM sleep behavior disorder (RBD): Update on diagnosis and treatment
por: Högl, Birgit, et al.
Publicado: (2016)

Insomnia and somnolence in idiopathic RBD: a prospective cohort study
por: Postuma, Ronald B., et al.
Publicado: (2017)

Antibodies and Vaccines Target RBD of SARS-CoV-2
por: Min, Long, et al.
Publicado: (2021)

Scanning the RBD-ACE2 molecular interactions in Omicron variant
por: Rath, Soumya Lipsa, et al.
Publicado: (2022)

Sodium oxybate—a new horizon for symptomatic treatment of RBD?
por: Stefani, Ambra, et al.
Publicado: (2023)

Impulse control disorders in Parkinson disease and RBD: A longitudinal study of severity
por: Baig, Fahd, et al.
Publicado: (2019)

A SARS-CoV-2 neutralizing antibody selected from COVID-19 patients binds to the ACE2-RBD interface and is tolerant to most known RBD mutations
por: Bertoglio, Federico, et al.
Publicado: (2021)

Analysis of the Microprocessor in Dictyostelium: The Role of RbdB, a dsRNA Binding Protein
por: Meier, Doreen, et al.
Publicado: (2016)

Structural Insight into the Recognition of r(UAG) by Musashi-1 RBD2, and Construction of a Model of Musashi-1 RBD1-2 Bound to the Minimum Target RNA
por: Iwaoka, Ryo, et al.
Publicado: (2017)

Effect of Delta and Omicron Mutations on the RBD-SD1 Domain of the Spike Protein in SARS-CoV-2 and the Omicron Mutations on RBD-ACE2 Interface Complex
por: Ching, Wai-Yim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rgt9a65h9mrutoj7iqq0f8ttgs